ArticleCNS neuroscience & therapeutics2026
Nurses' Attitudes Toward Innovative Neurotherapies in Memory Disorders: A Pilot Study.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAs the aging population increases, the prevalence of Alzheimer's disease and other memory disorders increases, and emerging neurotherapies offer new hope, yet little is known about nurses' knowledge and perspectives on these innovations, despite their critical role in patient care. This study aimed to investigate nurses' attitudes, expectations, concerns, and perspectives toward innovative therapies for memory disorders.
methodsA multiple-choice questionnaire (24 items) in Finnish was developed to explore nurses' views. The questionnaire was distributed via email to nursing homes in the Wellbeing Services County of North Savo, Finland, in autumn 2024. Composite scores for perceived benefits, perceived barriers, enabling factors, professional role-related responsibilities, and worries were generated for statistical analyses.
resultsA total of 132 nurses responded to the survey, most of whom were practical nurses working in nursing homes. Overall familiarity with innovative neurotherapies was low, and many participants indicated that they were not at all familiar with these treatments. Opinions on the future role of such therapies in managing memory disorders varied, with some considering them significant or moderately important. Several respondents also expressed serious concerns regarding the efficacy and potential side effects of these therapies. Regression analyses showed that lower composite outcome scores were consistently associated with being a social and healthcare student, being somewhat familiar with innovative neurotherapies, and, in some models, with shorter work experience or specific workplace settings. However, adjusted R
conclusionNurses currently have limited familiarity with innovative neurotherapies, but there is cautious optimism about their future role in treating memory disorders, including Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.